Why Are Pseudomonas Infections Getting Harder to Treat?

Marin H. Kollef, MD, explains why Pseudomonas infections are getting harder to treat.

Marin H. Kollef, MD, professor of medicine and Virginia E. & Sam J. Golman chair of the Respiratory Intensive Care department of Washington University School of Medicine, explains why Pseudomonas infections are getting harder to treat.

Related Videos
Related Content

World Tuberculosis Day: Easing the Continuum of Care Burden

March 24th 2023

C difficile, Antimicrobials, and the Patients Most Affected

November 23rd 2022

Hydrocortisone Lowers Risk of Death in Severe Community-Acquired Pneumonia

March 21st 2023

Vaccine Race: The Pfizer Vaccine with William Schaffner, MD

November 16th 2020

Patient Perspective: Dealing With Recurrent C diff

March 6th 2023

A Year After Acute Infection, Adults With Long COVID Had Increased Adverse Outcomes

March 4th 2023

World Tuberculosis Day: Easing the Continuum of Care Burden

March 24th 2023

C difficile, Antimicrobials, and the Patients Most Affected

November 23rd 2022

Hydrocortisone Lowers Risk of Death in Severe Community-Acquired Pneumonia

March 21st 2023

Vaccine Race: The Pfizer Vaccine with William Schaffner, MD

November 16th 2020

Patient Perspective: Dealing With Recurrent C diff

March 6th 2023

A Year After Acute Infection, Adults With Long COVID Had Increased Adverse Outcomes

March 4th 2023

World Tuberculosis Day: Easing the Continuum of Care Burden

March 24th 2023

C difficile, Antimicrobials, and the Patients Most Affected

November 23rd 2022

Hydrocortisone Lowers Risk of Death in Severe Community-Acquired Pneumonia

March 21st 2023

Vaccine Race: The Pfizer Vaccine with William Schaffner, MD

November 16th 2020

Patient Perspective: Dealing With Recurrent C diff

March 6th 2023

A Year After Acute Infection, Adults With Long COVID Had Increased Adverse Outcomes

March 4th 2023
© 2023 MJH Life Sciences

All rights reserved.